Business Description
West Pharmaceutical Services Inc
NAICS : 339112
SIC : 3841
ISIN : BRW2STBDR007
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.96 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | 0.38 | |||||
Interest Coverage | 79.18 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 20.52 | |||||
Beneish M-Score | -2.75 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.4 | |||||
3-Year EBITDA Growth Rate | 17.9 | |||||
3-Year EPS without NRI Growth Rate | 19.3 | |||||
3-Year FCF Growth Rate | 11.9 | |||||
3-Year Book Growth Rate | 16.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 6.87 | |||||
Future 3-5Y Total Revenue Growth Rate | 6.22 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 76.52 | |||||
9-Day RSI | 81.51 | |||||
14-Day RSI | 84.98 | |||||
6-1 Month Momentum % | 11.84 | |||||
12-1 Month Momentum % | 3.59 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.61 | |||||
Quick Ratio | 1.95 | |||||
Cash Ratio | 0.93 | |||||
Days Inventory | 86.97 | |||||
Days Sales Outstanding | 64.88 | |||||
Days Payable | 45.78 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.15 | |||||
Dividend Payout Ratio | 0.09 | |||||
3-Year Dividend Growth Rate | 5.8 | |||||
Forward Dividend Yield % | 0.14 | |||||
5-Year Yield-on-Cost % | 0.2 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 2.7 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 37.15 | |||||
Operating Margin % | 22.71 | |||||
Net Margin % | 19.42 | |||||
FCF Margin % | 13.16 | |||||
ROE % | 20.38 | |||||
ROA % | 15.3 | |||||
ROIC % | 21.53 | |||||
ROC (Joel Greenblatt) % | 33.69 | |||||
ROCE % | 21.55 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 48.23 | |||||
Forward PE Ratio | 52.36 | |||||
PE Ratio without NRI | 47.73 | |||||
Shiller PE Ratio | 73.74 | |||||
Price-to-Owner-Earnings | 55.67 | |||||
PEG Ratio | 2.17 | |||||
PS Ratio | 9.35 | |||||
PB Ratio | 9.96 | |||||
Price-to-Tangible-Book | 10.43 | |||||
Price-to-Free-Cash-Flow | 71.06 | |||||
Price-to-Operating-Cash-Flow | 36.23 | |||||
EV-to-EBIT | 38.96 | |||||
EV-to-Forward-EBIT | 37.65 | |||||
EV-to-EBITDA | 32.23 | |||||
EV-to-Forward-EBITDA | 30.9 | |||||
EV-to-Revenue | 8.99 | |||||
EV-to-Forward-Revenue | 8.75 | |||||
EV-to-FCF | 68.21 | |||||
Price-to-Projected-FCF | 4.03 | |||||
Price-to-DCF (Earnings Based) | 1.7 | |||||
Price-to-DCF (FCF Based) | 2.53 | |||||
Price-to-Median-PS-Value | 1.76 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.28 | |||||
Price-to-Graham-Number | 4.7 | |||||
Price-to-Net-Current-Asset-Value | 34.58 | |||||
Earnings Yield (Greenblatt) % | 2.57 | |||||
FCF Yield % | 1.45 | |||||
Forward Rate of Return (Yacktman) % | 21.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
West Pharmaceutical Services Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil R$) | 14,399.51 | ||
EPS (TTM) (R$) | 1.065 | ||
Beta | 0 | ||
Volatility % | 15.66 | ||
14-Day RSI | 84.98 | ||
14-Day ATR (R$) | 0.140966 | ||
20-Day SMA (R$) | 56.3755 | ||
12-1 Month Momentum % | 3.59 | ||
52-Week Range (R$) | 48.05 - 57.72 | ||
Shares Outstanding (Mil) | 2,549.64 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
West Pharmaceutical Services Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
West Pharmaceutical Services Inc Stock Events
Event | Date | Price(R$) | ||
---|---|---|---|---|
No Event Data |
West Pharmaceutical Services Inc Frequently Asked Questions
What is West Pharmaceutical Services Inc(BSP:W2ST34)'s stock price today?
When is next earnings date of West Pharmaceutical Services Inc(BSP:W2ST34)?
Does West Pharmaceutical Services Inc(BSP:W2ST34) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |